Third Rock Ventures Gp Ii, L.p. - Net Worth and Insider Trading

Over the past 18 months, Third Rock Ventures Gp Ii, L.p. made no insider transaction in Revolution Medicines Inc (RVMD). Other recent insider transactions involving Revolution Medicines Inc (RVMD) include a net sale of 91,644 shares made by Margaret A Horn , a net sale of 97,493 shares made by Stephen Michael Kelsey , and a net sale of 12,934 shares made by Jeff Cislini .

In summary, during the past 3 months, insiders sold 68,164 shares of Revolution Medicines Inc (RVMD) in total and bought 0 shares, with a net sale of 68,164 shares. During the past 18 months, 337,190 shares of Revolution Medicines Inc (RVMD) were sold and 650,000 shares were bought by its insiders, resulting in a net purchase of 312,810 shares.

Revolution Medicines Inc (RVMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of MyoKardia Inc (MYOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MyoKardia Inc (MYOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MyoKardia Inc (MYOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Allena Pharmaceuticals Inc (ALNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Allena Pharmaceuticals Inc (ALNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Allena Pharmaceuticals Inc (ALNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Third Rock Ventures Gp Ii, L.p. made no insider transaction in Blueprint Medicines Corp (BPMC). Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 175,899 shares made by Jeffrey W. Albers , a net sale of 11,217 shares made by Christopher K. Murray , and a net sale of 36,744 shares made by Michael Landsittel .

In summary, during the past 3 months, insiders sold 130,368 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 130,368 shares. During the past 18 months, 312,641 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 312,641 shares.

Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Third Rock Ventures Gp Ii, L.p. made no insider transaction in Jounce Therapeutics Inc (JNCE). Other recent insider transactions involving Jounce Therapeutics Inc (JNCE) include a net sale of 84,298 shares made by Richard /ca/ Murray , a net purchase of 85,987 shares made by Kevin C Tang , and a net sale of 16,634 shares made by Hugh M Cole .

In summary, during the past 3 months, insiders sold 0 shares of Jounce Therapeutics Inc (JNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 124,313 shares of Jounce Therapeutics Inc (JNCE) were sold and 85,987 shares were bought by its insiders, resulting in a net sale of 38,326 shares.

Jounce Therapeutics Inc (JNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Third Rock Ventures Gp Ii, L.p. made no insider transaction in Sage Therapeutics Inc (SAGE). Other recent insider transactions involving Sage Therapeutics Inc (SAGE) include a net purchase of 3,000 shares made by Elizabeth Barrett , a net purchase of 14,500 shares made by Barry E Greene , and a net sale of 11,643 shares made by Jeffrey M Jonas .

In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,643 shares of Sage Therapeutics Inc (SAGE) were sold and 17,500 shares were bought by its insiders, resulting in a net purchase of 5,857 shares.

Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.